A 2.5-year-old female patient was referred for the acute onset of bilateral blindness. She had a 6-week history of low-grade fever, nasal congestion, and clear rhinorrhea. Two days before admission she was lethargic, with decreasing visual acuity (walking into walls, etc.). She also had a history of strabismus.
. Axial CT scan images obtained pre-(A), mid-(B), and post-therapy (C). The 4 × 4-cm heterogenous tumor pushes on the palate and is centered on the nasopharynx, involving the orbital apex and distorting both orbital nerves (A) . At midtreatment, the mass's size has decreased to 3 × 2.5 cm (B). Post-treatment, a marked decrease is seen in the size of the nasopharyngeal mass (C). Post-treatment imaging studies showed resolution of the large nasopharyngeal mass and its involvement of the skull base and orbit (figures 1-3) . Endoscopic operative evaluation and biopsy confirmed the absence of residual tumor.
Four months post-treatment, the patient regained sight in the right eye with limited vision in the left. She is otherwise neurologically intact and has returned to prekindergarten.
YSTs are unusual occurrences in the head neck. They are usually derived from the testes or ovaries. Also known as endodermal sinus tumors, YSTs represent 3 to 5% of pediatric malignancies 1,2 and are malignant germ cell tumors that produce alpha-fetoprotein (AFP). Extragonadal lesions occur in approximately 20% of females, with an average age at presentation of 18 years. 3, 4 The most common extragonadal site is the vagina. Other extragonadal sites include the mediastinum, pelvis, and liver. In the head and neck, there have been reports in the nose, orbit, parotid gland, oral cavity, and esophagus.
Symptoms of YSTs depend on the site affected. The characteristic finding is rapid growth over a few weeks. Radiologic imaging with CT and MRI scans is usually required. A biopsy of the lesion with immunohistochemical staining is needed for confirmation of the diagnosis (reactive for keratin and AFP).
Successful treatment of this tumor requires preoperative chemotherapy followed by complete surgical extirpation of residual disease and postoperative chemotherapy as needed. [5] [6] [7] This treatment has a high success rate. 5 Radiotherapy is included as part of the armamentarium, primarily in non-head-and-neck sites. Serum AFP levels are measured and followed to monitor the tumor's response to chemotherapy, as it correlates well with tumor mass on neuroimaging. 
